Cargando…

Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming

T cell exhaustion is a hallmark of cancer and persistent infections, marked by inhibitory receptor upregulation, diminished cytokine secretion, and impaired cytolytic activity. Terminally exhausted T cells are steadily replenished by a precursor population (Tpex), but the metabolic principles govern...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hao, Zhao, Xiufeng, Hochrein, Sophia M., Eckstein, Miriam, Gubert, Gabriela F., Knöpper, Konrad, Mansilla, Ana Maria, Öner, Arman, Doucet-Ladevèze, Remi, Schmitz, Werner, Ghesquière, Bart, Theurich, Sebastian, Dudek, Jan, Gasteiger, Georg, Zernecke, Alma, Kobold, Sebastian, Kastenmüller, Wolfgang, Vaeth, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611730/
https://www.ncbi.nlm.nih.gov/pubmed/37891230
http://dx.doi.org/10.1038/s41467-023-42634-3
Descripción
Sumario:T cell exhaustion is a hallmark of cancer and persistent infections, marked by inhibitory receptor upregulation, diminished cytokine secretion, and impaired cytolytic activity. Terminally exhausted T cells are steadily replenished by a precursor population (Tpex), but the metabolic principles governing Tpex maintenance and the regulatory circuits that control their exhaustion remain incompletely understood. Using a combination of gene-deficient mice, single-cell transcriptomics, and metabolomic analyses, we show that mitochondrial insufficiency is a cell-intrinsic trigger that initiates the functional exhaustion of T cells. At the molecular level, we find that mitochondrial dysfunction causes redox stress, which inhibits the proteasomal degradation of hypoxia-inducible factor 1α (HIF-1α) and promotes the transcriptional and metabolic reprogramming of Tpex cells into terminally exhausted T cells. Our findings also bear clinical significance, as metabolic engineering of chimeric antigen receptor (CAR) T cells is a promising strategy to enhance the stemness and functionality of Tpex cells for cancer immunotherapy.